Comparative global epidemiology of influenza, respiratory syncytial and parainfluenza viruses, 2010-2015.


Journal

The Journal of infection
ISSN: 1532-2742
Titre abrégé: J Infect
Pays: England
ID NLM: 7908424

Informations de publication

Date de publication:
10 2019
Historique:
received: 29 11 2018
revised: 17 05 2019
accepted: 12 07 2019
pubmed: 20 7 2019
medline: 14 7 2020
entrez: 20 7 2019
Statut: ppublish

Résumé

To improve our understanding of the global epidemiology of common respiratory viruses by analysing their contemporaneous incidence at multiple sites. 2010-2015 incidence data for influenza A (IAV), influenza B (IBV), respiratory syncytial (RSV) and parainfluenza (PIV) virus infections were collected from 18 sites (14 countries), consisting of local (n = 6), regional (n = 9) and national (n = 3) laboratories using molecular diagnostic methods. Each site submitted monthly virus incidence data, together with details of their patient populations tested and diagnostic assays used. For the Northern Hemisphere temperate countries, the IAV, IBV and RSV incidence peaks were 2-6 months out of phase with those in the Southern Hemisphere, with IAV having a sharp out-of-phase difference at 6 months, whereas IBV and RSV showed more variable out-of-phase differences of 2-6 months. The tropical sites Singapore and Kuala Lumpur showed fluctuating incidence of these viruses throughout the year, whereas subtropical sites such as Hong Kong, Brisbane and Sydney showed distinctive biannual peaks for IAV but not for RSV and PIV. There was a notable pattern of synchrony of IAV, IBV and RSV incidence peaks globally, and within countries with multiple sampling sites (Canada, UK, Australia), despite significant distances between these sites.

Identifiants

pubmed: 31323249
pii: S0163-4453(19)30218-X
doi: 10.1016/j.jinf.2019.07.008
pmc: PMC7112594
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

373-382

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019. Published by Elsevier Ltd.

Références

Influenza Other Respir Viruses. 2013 May;7(3):312-20
pubmed: 22804910
Epidemiol Infect. 2016 Mar;144(4):751-67
pubmed: 26345289
BMC Infect Dis. 2016 Dec 19;16(1):762
pubmed: 27993136
J Infect Dis. 2012 Dec 15;206 Suppl 1:S74-9
pubmed: 23169976
Influenza Other Respir Viruses. 2018 May;12(3):383-411
pubmed: 29127742
PLoS One. 2017 May 25;12(5):e0177655
pubmed: 28542324
PLoS Med. 2009 Nov;6(11):e1000168
pubmed: 19918363
Clin Microbiol Infect. 2015 Sep;21(9):861-6
pubmed: 26033670
Ital J Pediatr. 2009 Jun 25;35:16
pubmed: 19555507
PLoS One. 2012;7(11):e48609
pubmed: 23139802
Lancet Infect Dis. 2017 Oct;17(10):e320-e326
pubmed: 28457597
Am J Infect Dis. 2013;9(3):77-93
pubmed: 26561480
Infect Genet Evol. 2017 Apr;49:241-250
pubmed: 28132927
BMC Infect Dis. 2018 Dec 27;18(1):695
pubmed: 30587159
Arch Dis Child. 2018 Jan;103(1):101-105
pubmed: 28855230
BMC Infect Dis. 2018 Mar 6;18(1):111
pubmed: 29510663
Rev Med Virol. 2014 Jan;24(1):15-34
pubmed: 24421259
PLoS One. 2014 Oct 23;9(10):e110713
pubmed: 25340711
Influenza Other Respir Viruses. 2019 Mar;13(2):138-147
pubmed: 30596225
BMC Infect Dis. 2015 Oct 24;15:447
pubmed: 26497393
Lancet. 2010 May 1;375(9725):1545-55
pubmed: 20399493
BMC Infect Dis. 2013 Jan 23;13:28
pubmed: 23343342
Annu Rev Genomics Hum Genet. 2016 Aug 31;17:193-218
pubmed: 27216777
J Med Virol. 2019 Mar;91(3):498-502
pubmed: 30199092
PLoS One. 2013;8(2):e54445
pubmed: 23457451
Semin Respir Crit Care Med. 2007 Apr;28(2):182-92
pubmed: 17458772
J Infect Dis. 2018 Apr 11;217(9):1356-1364
pubmed: 29390105
J R Soc Interface. 2015 Nov 6;12(112):
pubmed: 26559683

Auteurs

Tommy T Lam (TT)

State Key Laboratory of Emerging Infectious Diseases, School of Public Health, The University of Hong Kong, Hong Kong SAR, China.

Julian W Tang (JW)

Clinical Microbiology, University Hospitals Leicester, Level 5 Sandringham Building, Leicester Royal Infirmary, Infirmary Square, Leicester LE1 5WW, UK. Electronic address: julian.tang@uhl-tr.nhs.uk.

Florence Y Lai (FY)

Cardiovascular Biomedical Research Unit, University of Leicester, Leicester, UK.

Hassan Zaraket (H)

Faculty of Medicine, American University of Beirut, Beirut, Lebanon.

Ghassan Dbaibo (G)

Faculty of Medicine, American University of Beirut, Beirut, Lebanon.

Seweryn Bialasiewicz (S)

Child Health Research Centre, The University of Queensland, Brisbane, Australia; Children's Health Queensland, Brisbane, Australia.

Sarah Tozer (S)

Child Health Research Centre, The University of Queensland, Brisbane, Australia; Children's Health Queensland, Brisbane, Australia.

Jean-Michel Heraud (JM)

National Influenza Center, Virology Unit, Institut Pasteur de Madagascar, Antananarivo 101, Madagascar.

Steven J Drews (SJ)

Alberta Provincial Laboratory for Public Health, University of Alberta, Edmonton, AB, Canada.

Todd Hachette (T)

Department of Pathology, Dalhousie University, Halifax, NS, Canada.

Paul Ks Chan (PK)

Department of Microbiology, The Chinese University of Hong Kong SAR, Hong Kong, China.

Evelyn Sc Koay (ES)

Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

Hong Kai Lee (HK)

Molecular Diagnosis Centre, National University Hospital, Singapore.

Kok Keng Tee (KK)

Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Yang Liu (Y)

State Key Laboratory of Emerging Infectious Diseases, School of Public Health, The University of Hong Kong, Hong Kong SAR, China.

Pieter LA Fraaij (P)

Department of Pediatrics, Erasmus Medical Centre, Rotterdam, Netherlands; ViroScience, Erasmus Medical Centre, Rotterdam, Netherlands.

Lance Jennings (L)

Pathology Department, University of Otago, Christchurch, New Zealand.

Matti Waris (M)

Institute of Biomedicine, University of Turku, Finland; Clinical Microbiology, Turku University Hospital, Turku, Finland.

Mel Krajden (M)

British Columbia Centre for Disease Prevention and Control, Vancouver, BC, Canada.

André Corriveau (A)

Government of the Northwest Territories, Yellowknife, NT, Canada.

Hamid Jalal (H)

Department of Pathology, Addenbrookes Hospital, Cambridge, UK.

Hidekazu Nishimura (H)

Virus Research Center, Sendai Medical Center, Sendai, Japan.

Pagbajabyn Nymadawa (P)

Laboratory of Virology, National Center for Communicable Diseases, Ulaanbaatar, Mongolia.

Darmaa Badarch (D)

Laboratory of Virology, National Center for Communicable Diseases, Ulaanbaatar, Mongolia.

Aripuana Watanabe (A)

Department of Parasitology, Microbiology and Immunology, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil.

Alice Kabanda (A)

National Reference Laboratory, Kigali, Rwanda.

Theo Sloots (T)

Child Health Research Centre, The University of Queensland, Brisbane, Australia; Children's Health Queensland, Brisbane, Australia.

Jen Kok (J)

NSWHP-ICPMR, Westmead Hospital, Sydney, Australia; Pathology and Infectious Diseases, University of Sydney, Sydney, Australia.

Dominic E Dwyer (DE)

NSWHP-ICPMR, Westmead Hospital, Sydney, Australia; Pathology and Infectious Diseases, University of Sydney, Sydney, Australia.

Marion Koopmans (M)

ViroScience, Erasmus Medical Centre, Rotterdam, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH